Genome-wide approaches to systematically identify substrates of the ubiquitin-proteasome pathway.

Trends in Biotechnology
Chang LiuHai Rao

Abstract

The ubiquitin-proteasome system handles the majority of controlled proteolysis in eukaryotes. Defects in the ubiquitin-proteasome system have been implicated in diseases ranging from cancers to neurodegenerative disorders. However, the precise role of ubiquitin-proteasome-mediated degradation in health and disease is far from clear. A major challenge is to link specific substrates directly to a particular degradation pathway. Here, we review genome-wide approaches that have been developed in recent years to comprehensively identify ubiquitylated substrates of a particular pathway. Components of the ubiquitin-proteasome system are attractive drug targets, as illustrated by the efficacy of some proteasome inhibitors in the treatment of multiple myeloma. Information that has emerged from these studies could reveal novel drug targets and strategies for treating human diseases.

References

Jan 10, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E KamyninaO Staub
Oct 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Amy L HitchcockPamela A Silver
Mar 23, 2005·Nature Methods·Julie PerroyMichel Bouvier
Jun 14, 2005·Trends in Biochemical Sciences·Alexander Varshavsky
Aug 2, 2005·Nature Cell Biology·Donald S KirkpatrickSteven P Gygi
Feb 4, 2006·Molecular Cell·Richelle SopkoBrenda Andrews
Apr 12, 2006·Genome Biology·Jay R HesselberthStanley Fields
Aug 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Archana BelleErin K O'Shea
Sep 23, 2006·Nature Reviews. Cancer·Daniela HoellerIvan Dikic
Oct 24, 2006·Biochimica Et Biophysica Acta·Ping Xu, Junmin Peng
Dec 22, 2006·Molecular Biology of the Cell·Matthew W McNattGreg Odorizzi
Mar 3, 2007·Molecular Biology of the Cell·Hadiya Watson, Juan S Bonifacino
Sep 11, 2007·Nature Cell Biology·Jennifer A BenantiDavid P Toczyski
Oct 3, 2007·Cancer Research·Shahab AkhoondiCharles Spruck
Oct 19, 2007·Expert Review of Proteomics·Xiaorong WangLan Huang
Oct 24, 2007·Molecular & Cellular Proteomics : MCP·Jin-Ying LuHeng Zhu
Dec 6, 2007·BMC Biochemistry·Timothy Cardozo, Michele Pagano
Mar 21, 2008·Analytical Chemistry·Ping Xu, Junmin Peng
Apr 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Reena ShakyaThomas Ludwig
May 27, 2008·Nature Reviews. Cancer·David Frescas, Michele Pagano
Aug 14, 2008·Nature Reviews. Molecular Cell Biology·Tommer Ravid, Mark Hochstrasser
Sep 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Tsutomu KishiRina Nagao
Oct 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Scott J DixonCharles Boone
Nov 8, 2008·Science·Hsueh-Chi Sherry YenStephen J Elledge
Nov 8, 2008·Science·Hsueh-Chi Sherry Yen, Stephen J Elledge
Nov 26, 2008·BMC Biochemistry·Daniela Rotin
Jan 10, 2009·Nature Biotechnology·Donald S Kirkpatrick, Vishva M Dixit
Jan 21, 2009·Cell Division·Min Li, Pumin Zhang
Feb 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yifat Merbl, Marc W Kirschner
Mar 4, 2009·Chemical Reviews·Mark Hochstrasser
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Thomas Joos, Jutta Bachmann
Mar 14, 2009·Trends in Biochemical Sciences·Kevin D Sarge, Ok-Kyong Park-Sarge

❮ Previous
Next ❯

Citations

May 24, 2012·Stroke; a Journal of Cerebral Circulation·Yuji UenoZheng Gang Zhang
Oct 16, 2010·Biomarkers in Medicine·Grisel Lopez, Ellen Sidransky
Aug 31, 2013·Nature Reviews. Molecular Cell Biology·Debora L MakinoElena Conti
Jan 26, 2020·Nature Communications·Kirby Martinez-FontsAndreas Matouschek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.